Rekah Pharmaceutical Industry Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
REKA
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 78.59M 108M | Sales 2023 | 322M 86.45M 118M | Capitalization | 169M 45.34M 62.11M |
---|---|---|---|---|---|
Net income 2022 | -2M -538K -736K | Net income 2023 | -6M -1.61M -2.21M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 39.08M 53.53M | Net Debt 2023 | 166M 44.74M 61.28M | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 93-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Director/Board Member | 78 | 93-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-14 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-14 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-14 |
1st Jan change | Capi. | |
---|---|---|
+20.41% | 72.78B | |
-2.07% | 24.24B | |
+8.80% | 8.59B | |
+9.15% | 8.38B | |
-17.39% | 8.09B | |
+7.33% | 4.81B | |
+17.69% | 4.32B | |
-3.66% | 4.05B | |
-2.54% | 3.93B |